1
|
Lee SW, Park HJ, Van Kaer L, Hong S. Role of CD1d and iNKT cells in regulating intestinal inflammation. Front Immunol 2024; 14:1343718. [PMID: 38274786 PMCID: PMC10808723 DOI: 10.3389/fimmu.2023.1343718] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2023] [Accepted: 12/26/2023] [Indexed: 01/27/2024] Open
Abstract
Invariant natural killer T (iNKT) cells, a subset of unconventional T cells that recognize glycolipid antigens in a CD1d-dependent manner, are crucial in regulating diverse immune responses such as autoimmunity. By engaging with CD1d-expressing non-immune cells (such as intestinal epithelial cells and enterochromaffin cells) and immune cells (such as type 3 innate lymphoid cells, B cells, monocytes and macrophages), iNKT cells contribute to the maintenance of immune homeostasis in the intestine. In this review, we discuss the impact of iNKT cells and CD1d in the regulation of intestinal inflammation, examining both cellular and molecular factors with the potential to influence the functions of iNKT cells in inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.
Collapse
Affiliation(s)
- Sung Won Lee
- Department of Biomedical Laboratory Science, College of Health and Biomedical Services, Sangji University, Wonju, Republic of Korea
| | - Hyun Jung Park
- Department of Integrative Bioscience and Biotechnology, Institute of Anticancer Medicine Development, Sejong University, Seoul, Republic of Korea
| | - Luc Van Kaer
- Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, United States
| | - Seokmann Hong
- Department of Integrative Bioscience and Biotechnology, Institute of Anticancer Medicine Development, Sejong University, Seoul, Republic of Korea
| |
Collapse
|
2
|
Tsuji M, Nair MS, Masuda K, Castagna C, Chong Z, Darling TL, Seehra K, Hwang Y, Ribeiro ÁL, Ferreira GM, Corredor L, Coelho-Dos-Reis JGA, Tsuji Y, Mori M, Boon ACM, Diamond MS, Huang Y, Ho DD. An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo. Nat Commun 2023; 14:3959. [PMID: 37402814 DOI: 10.1038/s41467-023-39738-1] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2023] [Accepted: 06/27/2023] [Indexed: 07/06/2023] Open
Abstract
Prophylactic vaccines for SARS-CoV-2 have lowered the incidence of severe COVID-19, but emergence of viral variants that are antigenically distinct from the vaccine strains are of concern and additional, broadly acting preventive approaches are desirable. Here, we report on a glycolipid termed 7DW8-5 that exploits the host innate immune system to enable rapid control of viral infections in vivo. This glycolipid binds to CD1d on antigen-presenting cells and thereby stimulates NKT cells to release a cascade of cytokines and chemokines. The intranasal administration of 7DW8-5 prior to virus exposure significantly blocked infection by three different authentic variants of SARS-CoV-2, as well as by respiratory syncytial virus and influenza virus, in mice or hamsters. We also found that this protective antiviral effect is both host-directed and mechanism-specific, requiring both the CD1d molecule and interferon-[Formula: see text]. A chemical compound like 7DW8-5 that is easy to administer and cheap to manufacture may be useful not only in slowing the spread of COVID-19 but also in responding to future pandemics long before vaccines or drugs are developed.
Collapse
Affiliation(s)
- Moriya Tsuji
- Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center, New York, NY, 10032, USA.
- Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA.
| | - Manoj S Nair
- Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center, New York, NY, 10032, USA
- Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA
| | - Kazuya Masuda
- Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center, New York, NY, 10032, USA
- Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA
| | - Candace Castagna
- Institute of Comparative Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA
| | - Zhenlu Chong
- Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA
| | - Tamarand L Darling
- Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA
| | - Kuljeet Seehra
- Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA
| | - Youngmin Hwang
- Columbia Center for Human Development, Pulmonary Allergy & Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA
| | - Ágata Lopes Ribeiro
- Basic and Applied Virology Laboratory, Department of Microbiology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | - Geovane Marques Ferreira
- Basic and Applied Virology Laboratory, Department of Microbiology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | - Laura Corredor
- Institute of Comparative Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA
| | | | - Yukiko Tsuji
- Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center, New York, NY, 10032, USA
| | - Munemasa Mori
- Columbia Center for Human Development, Pulmonary Allergy & Critical Care Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA
| | - Adrianus C M Boon
- Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA
- Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, 63110, USA
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA
| | - Michael S Diamond
- Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA
- Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, 63110, USA
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA
- The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, 63110, USA
| | - Yaoxing Huang
- Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center, New York, NY, 10032, USA.
- Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA.
| | - David D Ho
- Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center, New York, NY, 10032, USA.
- Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA.
- Department of Microbiology and Immunology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, 10032, USA.
| |
Collapse
|
3
|
Watson FN, Duncombe CJ, Kalata AC, Conrad E, Chakravarty S, Sim BKL, Hoffman SL, Tsuji M, Shears MJ, Murphy SC. Sex-Specific Differences in Cytokine Induction by the Glycolipid Adjuvant 7DW8-5 in Mice. Biomolecules 2022; 13:biom13010008. [PMID: 36671393 PMCID: PMC9855660 DOI: 10.3390/biom13010008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2022] [Revised: 12/16/2022] [Accepted: 12/16/2022] [Indexed: 12/24/2022] Open
Abstract
7DW8-5 is a potent glycolipid adjuvant that improves malaria vaccine efficacy in mice by inducing IFN-γ and increasing protective CD8+ T cell responses. The addition of 7DW8-5 was previously shown to improve the efficacy of a CD8+ T cell-mediated heterologous 'prime-and-trap' malaria vaccine against Plasmodium yoelii sporozoite challenge in inbred female mice. Here, we report significant differential sex-specific responses to 7DW8-5 in inbred and outbred mice. Male mice express significantly less IFN-γ and IL-4 compared to females following intravenous 7DW8-5 administration. Additionally, unlike in female mice, 7DW8-5 did not improve the vaccine efficacy against sporozoite challenge in prime-and-trap vaccinated male mice. Our findings highlight the importance of including both female and male sexes in experimental adjuvant studies.
Collapse
Affiliation(s)
- Felicia N. Watson
- Graduate Program in Pathobiology, Department of Global Health, University of Washington, Seattle, WA 98109, USA
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98109, USA
- Center for Emerging and Re-Emerging Infectious Diseases (CERID), University of Washington, Seattle, WA 98109, USA
| | - Caroline J. Duncombe
- Graduate Program in Pathobiology, Department of Global Health, University of Washington, Seattle, WA 98109, USA
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98109, USA
- Center for Emerging and Re-Emerging Infectious Diseases (CERID), University of Washington, Seattle, WA 98109, USA
| | - Anya C. Kalata
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98109, USA
- Center for Emerging and Re-Emerging Infectious Diseases (CERID), University of Washington, Seattle, WA 98109, USA
| | - Ethan Conrad
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98109, USA
- Center for Emerging and Re-Emerging Infectious Diseases (CERID), University of Washington, Seattle, WA 98109, USA
| | - Sumana Chakravarty
- Sanaria Inc., 9800 Medical Center Drive, Suite A209, Rockville, MD 20850, USA
| | - B. Kim Lee Sim
- Sanaria Inc., 9800 Medical Center Drive, Suite A209, Rockville, MD 20850, USA
| | - Stephen L. Hoffman
- Sanaria Inc., 9800 Medical Center Drive, Suite A209, Rockville, MD 20850, USA
| | - Moriya Tsuji
- Aaron Diamond AIDS Research Center, Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY 10032, USA
| | - Melanie J. Shears
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98109, USA
- Center for Emerging and Re-Emerging Infectious Diseases (CERID), University of Washington, Seattle, WA 98109, USA
| | - Sean C. Murphy
- Graduate Program in Pathobiology, Department of Global Health, University of Washington, Seattle, WA 98109, USA
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98109, USA
- Center for Emerging and Re-Emerging Infectious Diseases (CERID), University of Washington, Seattle, WA 98109, USA
- Department of Microbiology, University of Washington, Seattle, WA 98109, USA
- Washington National Primate Research Center, University of Washington, Seattle, WA 98109, USA
- Department of Laboratories, Seattle Children’s Hospital, Seattle, WA 98109, USA
- Correspondence:
| |
Collapse
|
4
|
Li X, Xin S, Zheng X, Lou L, Ye S, Li S, Wu Q, Ding Q, Ji L, Nan C, Lou Y. Inhibition of the Occurrence and Development of Inflammation-Related Colorectal Cancer by Fucoidan Extracted from Sargassum fusiforme. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2022; 70:9463-9476. [PMID: 35858119 PMCID: PMC9354242 DOI: 10.1021/acs.jafc.2c02357] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/05/2022] [Revised: 07/08/2022] [Accepted: 07/08/2022] [Indexed: 05/14/2023]
Abstract
Fucoidan has many biological activities, including the inhibitory effect on the development of various cancer types. This study showed that lipopolysaccharide-induced inflammation in FHC cells (normal human colonic epithelial cells) could be reversed using fucoidan at different concentrations. The fucoidan-induced anti-inflammatory effect was also confirmed through in vivo experiments in mice. Compared to the mice of the model group, the ratio of Firmicutes/Bacteroidetes in feces increased and the diversity of gut microbial composition was restored in mice after fucoidan intervention. In colorectal cancer (CRC) cells DLD-1 and SW480, fucoidan inhibited cell proliferation and promoted cell apoptosis. It also blocked the cell cycle of DLD-1 and SW480 at the G0/G1 phase. The animal model of inflammation-related CRC showed that the incidence of tumors in mice was significantly reduced by fucoidan intervention. Furthermore, the administration of fucoidan decreased the expression levels of inflammatory factors such as TNF-α IL-6 and IL-1β in the colonic tissues. Therefore, fucoidan can effectively prevent the development of colitis-associated CRC.
Collapse
Affiliation(s)
- Xiang Li
- Wenzhou
Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory
Medicine, Ministry of Education, China, School of Laboratory Medicine
and Life Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China
- Colorectal
Cancer Research Center, Wenzhou Medical
University, Wenzhou 325035, Zhejiang, China
| | - Shijun Xin
- Wenzhou
Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory
Medicine, Ministry of Education, China, School of Laboratory Medicine
and Life Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China
- Colorectal
Cancer Research Center, Wenzhou Medical
University, Wenzhou 325035, Zhejiang, China
| | - Xiaoqun Zheng
- Wenzhou
Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory
Medicine, Ministry of Education, China, School of Laboratory Medicine
and Life Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China
- Colorectal
Cancer Research Center, Wenzhou Medical
University, Wenzhou 325035, Zhejiang, China
| | - Liqin Lou
- Wenzhou
Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory
Medicine, Ministry of Education, China, School of Laboratory Medicine
and Life Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China
- Colorectal
Cancer Research Center, Wenzhou Medical
University, Wenzhou 325035, Zhejiang, China
| | - Shiqing Ye
- Wenzhou
Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory
Medicine, Ministry of Education, China, School of Laboratory Medicine
and Life Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China
- Colorectal
Cancer Research Center, Wenzhou Medical
University, Wenzhou 325035, Zhejiang, China
| | - Shengkai Li
- Wenzhou
Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory
Medicine, Ministry of Education, China, School of Laboratory Medicine
and Life Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China
- Colorectal
Cancer Research Center, Wenzhou Medical
University, Wenzhou 325035, Zhejiang, China
| | - Qilong Wu
- Wenzhou
Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory
Medicine, Ministry of Education, China, School of Laboratory Medicine
and Life Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China
- Colorectal
Cancer Research Center, Wenzhou Medical
University, Wenzhou 325035, Zhejiang, China
| | - Qingyong Ding
- Wenzhou
Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory
Medicine, Ministry of Education, China, School of Laboratory Medicine
and Life Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China
- Colorectal
Cancer Research Center, Wenzhou Medical
University, Wenzhou 325035, Zhejiang, China
| | - Ling Ji
- Colorectal
Cancer Research Center, Wenzhou Medical
University, Wenzhou 325035, Zhejiang, China
- The
First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325035, Zhejiang, China
| | - Chunrong Nan
- Wenzhou
Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory
Medicine, Ministry of Education, China, School of Laboratory Medicine
and Life Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China
| | - Yongliang Lou
- Wenzhou
Key Laboratory of Sanitary Microbiology, Key Laboratory of Laboratory
Medicine, Ministry of Education, China, School of Laboratory Medicine
and Life Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China
- Colorectal
Cancer Research Center, Wenzhou Medical
University, Wenzhou 325035, Zhejiang, China
| |
Collapse
|